Segmentation by type of HTS service further refines the market taxonomy, outlining the methodological foundations that underpin each application. Biochemical assays (≈35 % of services) focus on purified proteins or enzymes, with subtypes such as enzyme‑activity, receptor‑binding, and reporter‑gene assays that quantify direct molecular interactions. Cell‑based assays (≈30 %) evaluate compound effects in living cells, encompassing viability, signaling‑pathway, and reporter‑gene readouts, crucial for assessing cellular context. Target‑based assays (≈20 %) are designed around specific molecular targets, often employing binding‑affinity or functional readouts to prioritize hits. Phenotypic assays (≈10 %) capture holistic cellular or organismal responses without predefined targets, enabling discovery of novel mechanisms. A small Hybrid/Custom assay segment (≈5 %) addresses bespoke screening needs that combine elements of the above categories. By delineating these subtypes, analysts can attribute revenue streams to the technical complexity and resource requirements inherent in each service type.